Skip to Main Content

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Conditions

Other Hematopoietic | Pediatrics | Non Therapeutic | Sickle Cell Disorders

What is the purpose of this trial?

To compare donors to their non-donor counterparts and healthy controls as well as to generate trajectory classes based on longitudinal patterns of donor HRQoL and identify predictors of poor donor HRQoL.

  • Trial with
    National Marrow Donor Program
  • Start Date
    03/16/2022
  • End Date
    12/01/2021

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    03/18/2022
  • Study HIC
    #2000024877